+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Intravenous Iron"

From
Global IV & Oral Iron Drugs Market - Focused Insights 2024-2029 - Product Thumbnail Image

Global IV & Oral Iron Drugs Market - Focused Insights 2024-2029

  • Report
  • February 2024
  • 126 Pages
  • Global
From
Chemotherapy Induced Anemia - Pipeline Insight, 2024 - Product Thumbnail Image

Chemotherapy Induced Anemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
From
From
From
Drug Overview: Feraheme - Product Thumbnail Image

Drug Overview: Feraheme

  • Drug Pipelines
  • January 2018
  • 8 Pages
  • Global
From
Drug Overview: Dexferrum - Product Thumbnail Image

Drug Overview: Dexferrum

  • Drug Pipelines
  • January 2018
  • 8 Pages
  • Global
From
Drug Overview: Feraccru - Product Thumbnail Image

Drug Overview: Feraccru

  • Drug Pipelines
  • January 2018
  • 15 Pages
  • Global
From
From
  • 14 Results (Page 1 of 1)
Loading Indicator

The Intravenous Iron market is a segment of the Hematological Drugs market, which includes drugs used to treat anemia and other blood disorders. Intravenous Iron is a type of drug used to treat iron deficiency anemia, a condition in which the body does not have enough iron to produce healthy red blood cells. Intravenous Iron is administered directly into the bloodstream, allowing for a more rapid increase in iron levels than oral iron supplements. Intravenous Iron is used in a variety of settings, including hospitals, clinics, and home care. It is often prescribed to patients who are unable to take oral iron supplements due to gastrointestinal issues or who require a more rapid increase in iron levels. The Intravenous Iron market is highly competitive, with a number of companies offering products in this space. Some of the major players in the market include Vifor Pharma, Fresenius Kabi, American Regent, and B. Braun. Show Less Read more